Link
Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States
Organization: Johns Hopkins Bloomberg School of Public HealthPublished: 2020
"In this report, we compare the implications of our framework to the prior CDC guidance for prioritization of pandemic influenza vaccine allocation and suggest candidate groups who should be given serious consideration for inclusion in the top allocation tier when vaccine availability is limited and in a second tier (those also prioritized before the general public) if/when more vaccine supply becomes available. We also discuss how COVID-19 vaccines should be distributed so as to reach these 2 tiers." - Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States
Resource Group:
Implementation Tool
Product Type: Report
Vaccine Management
Allocation and Distribution
Policy
Immunization Policies
Evaluations
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Product Type: Report
Category:
Program Planning and Delivery,Vaccine Management,Allocation and Distribution,Policy,Immunization Policies,Evaluations,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Program Planning and DeliveryVaccine Management
Allocation and Distribution
Policy
Immunization Policies
Evaluations
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Audience:
Health Care Professional
Policy Makers
Population: Infants
Children (All)
High Risk Children
Adults
High Risk Adults
Pregnant and Breastfeeding People
Seniors
Healthcare Personnel
Region: United States
Policy Makers
Population: Infants
Children (All)
High Risk Children
Adults
High Risk Adults
Pregnant and Breastfeeding People
Seniors
Healthcare Personnel
Region: United States
Language:
English
AudioResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.